pharma · Venous leg ulcer
MediWound
MediWound Germany GmbH
MediWound Germany is a pharma organization headquartered in EU. Primary therapeutic focus areas include Venous leg ulcer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this enti
Yavne, EU HQ
2001 Founded
118 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Yavne, EU
- Founded
- 2001
- Employees
- 118
- Programs
- 1
- Drugs
- 1
- Patents
- 0
MW2022-06-22
Phase 3 · small molecule · Venous leg ulcer
MW2022-06-22 for Venous leg ulcer is a Phase 3 program (small_molecule) at MediWound Germany GmbH with 1 ClinicalTrials.gov record(s).
Internal code MW2022-06-22
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- MediWound Germany GmbH
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Venous leg ulcer
- Status
- active
- Trials
- 1